M/s ICPA Health Products (P) Ltd. Vs. Commissioner of Central Excise, Vadodara
(From the Judgment and Order dated 01.05.98 of the Central Excise, Customs and Gold (Control Appellate Tribunal, New Delhi in F. O. Nos. 320-22/98-C in A. Nos. E-770 of 1992-C and E/38-39 of 1995-C)
(From the Judgment and Order dated 01.05.98 of the Central Excise, Customs and Gold (Control Appellate Tribunal, New Delhi in F. O. Nos. 320-22/98-C in A. Nos. E-770 of 1992-C and E/38-39 of 1995-C)
Mr. Soli J. Sorabji, Attorney General for India, Ms. Vibha Makhija, Mr. B. Krishna Prasad, Advocates with him for the Respondent.
Central excise duty – Classification of goods for rate purposes – Hexiprep, Hexiaque and Hexiscrub having therapeutic properties and used for various processes of surgery by doctors – Whether to be classified as “patent or proprietary medicaments” under Tariff Item 3003.10 or as ‘disinfectants’ under Tariff Item 38.08. Held that since the Chemical Examiner who examined the products had opined that products contained therapeutic properties and were used for disinfecting the skin prior to surgery and also had prophylactic uses they fall under Chapter 30 and should be classified only as medicaments and not under Chapter 38. (Para 5)
1. These appeals are against the judgment of the Customs, Excise and Gold (Control) Appellate Tribunal (for short CEGAT) dated 1st May, 1998.
2. Briefly stated the facts are as follows:
The appellants manufacture, amongst other things, Hexiprep, Hexiscrub (Surgiscrub) and Hexiaque. They classified these items under tariff item 3003.10 and paid duty under notification no. 29/88-CE dated 1st March, 1988. Eight show-cause-notices were issued to them calling upon them to show cause as to why the products should not be classified under tariff item 38.08. The adjudicating authority then upheld the classification as proposed in the show-cause-notices. The appeal filed by the appellants to CEGAT has been dismissed by the impugned judgment.
3. The three products of the appellants were examined by the chemical examiner who opined that they contained chlorhexdine gluconate solution BP, which had therapeutic properties. The chemical examiner also opined that they were used as disinfectants and were thus covered by Tariff Entry 38.08.
4. The labels of the three products describe them as “superior surgical microbicidal solution”. It is admitted that Hexiprep is used to paint the skin as required to disinfect the skin before surgery. It is for rapid skin disinfection prior to surgery. Hexiaque is used as a skin disinfectant to paint the skin before surgery and as a wound disinfectant. It is described as a cleanser and is used for cleansing of wounds and abrasions and minor cuts. Hexiscrub is for use on hands and forearms of surgeons for rapid hand disinfection prior to surgery.
5. At this stage, the two Tariff Items may be set out. Tariff Item 3003.10 reads as follows:
“3003.10 – Patent or proprietary medicaments, other than those medicaments which are exclusively Ayurvedic, Unani, Siddha, Homoeopathic or Bio-chemic.”
Tariff Item No. 38.08 reads as follows:
“38.08 – Insecticides, rodenticides, fungicides, herbicides, anti-sprouting products and plant-growth regulators, disinfectants and similar products.”
CEGAT has held that the appellants’ products are disinfectants and are therefore covered under Tariff Item 38.08. However, Chapter Note 1(c) of Chapter 38, in which Tariff Item 38.08 falls, indicates that the Chapter does not apply to “medicaments”. Chapter Note 2(i) to Chapter 30 defines “medicaments” as follows:
” ‘Medicaments’ means goods (other than foods or beverages such as dietetic, diabetic or fortified foods, tonic beverages) not falling within heading no. 30.02 or 30.04 which are either :-
(a) products comprising two or more constituents which have been mixed or compounded together for therapeutic or prophylactic uses; or (b) unmixed products suitable for such uses put up in measured doses or in packings for retail sale or for use in hospitals.”
Thus, if a product comprises of two or more constituents which have been mixed together for therapeutic or prophylactic uses, then it would be a medicament. As stated above, the appellants’ products were examined by the chemical examiner who has opined that these products have therapeutic properties. Also admittedly these products are used for disinfecting the skin prior to surgery. As per Concise Oxford Dictionary, 9th Edition, the term “prophylactic” would mean “intending to prevent diseases, a preventive medicine or course of action”. It is clear that the appellants’ products are used as a cleanser for cleaning of wounds and abrasions and minor cuts and to disinfect the skin prior to surgery. They therefore also have prophylactic uses. As the products have therapeutic properties and prophylactic uses they are medicament falling under Chapter 30. As they fall under Chapter 30 by virtue of Note 1(c) to Chapter 38, they do not fall within Chapter 38. It will therefore have to be held that the products cannot be classified under Tariff Item 38.08. In this view of the matter, the impugned judgment cannot be sustained and is accordingly set aside. It is held that the appellants’ products will be classifiable under tariff item 3003.10.
6. The appeals are accordingly allowed. There will be no order as to costs.